Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Blueberry Therapeutics Secures £750,000 Investment from NPIF - Maven Equity Fund
NPIF – Maven Equity Finance, managed by Maven Capital Partners (“Maven”) and part of the […]
Advent France Biotechnology (AFB) Appoints Sidonie Fabre as CFO
Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, today announces the […]
UnitedHealthcare Awards $275,000 in Maternal Health Grants to Seven Community Organizations in Louisiana
UnitedHealthcare Community Plan of Louisiana has awarded $275,000 in maternal health grants to seven community […]
Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance
Helix, the leading population genomics and COVID-19 testing company, has closed on its Series C […]
Government and Life Science Industry Join Forces on 100 Days Mission for Future Pandemics
Life science industry leaders are joining forces with governments to step up collective efforts to […]
The Bill & Melinda Gates Foundation Pledges $50 Million to Increase Access to Safe and Affordable COVID-19 Vaccines in Lower-income Countries
The Bill & Melinda Gates Foundation today announced a $50 million commitment to Gavi, the […]
Ada Health Secures £63m Investment to Enhance Assessment Tech
Ada Health has secured $90m (£63m) in funding to enhance its health assessment technology. The […]
Theseus Pharmaceuticals Appoints Brad Dahms as Chief Financial Officer
Theseus Pharmaceuticals, a biotechnology company shaping the future of targeted oncology by developing best-in-class, pan-variant […]
Vortex Biosciences Announces Dr. Adrian Kinkaid as New CEO
Vortex Biosciences, the cancer diagnosis biotechnology business, has announced the appointment of Dr Adrian Kinkaid […]
Eddie Gray Appointed Chair of Antivirals Taskforce
The UK government has appointed Eddie Gray as the new chair of the Antivirals Taskforce. […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more